From: Surgical management of spontaneous posterior fossa hematoma: predictors of the neurological outcome
Patient data | No. (%) |
---|---|
Gender | |
Male/Female | 20 (44.4%) / 25 (55.6%) |
Age | 61.2 + 13.5 years (range 22–73 years) |
Clinical symptoms | |
Conscious level (GCS) at admission | |
GCS (14–15) | 17 (37.8%) |
GCS (13–9) | 24 (53.3%) |
GCS (8–5) | 4 (8.9%) |
Dizziness | 15 (33.3%) |
Nausea, vomiting | 10 (22.2%) |
Headache | 6 (13.3%) |
Seizure | 4 (8.9%) |
Dysarthria | 3 (6.6%) |
Ataxia | 2 (4.5%) |
Medical Co morbidities | |
Hypertension | 40 (88.9%) |
Cardiac | 16 (35.6%) |
Diabetes mellitus | 14 (31.1%) |
Liver disease | 6 (13.3%) |
Anti-platelets | 18 (40%) |
Anti-coagulants | 15 (33.3%) |